Helicoid peripapillary chorioretinal degeneration complicated by choroidal neovascularization
Autor: | Panagiotis Nanos, Doukas Dardabounis, Georgios D Panos, Aristeidis Konstantinidis, Magdalini Triantafylla |
---|---|
Rok vydání: | 2015 |
Předmět: |
Retinal degeneration
Male Vascular Endothelial Growth Factor A medicine.medical_specialty Visual acuity genetic structures Visual Acuity Angiogenesis Inhibitors Fundus (eye) 03 medical and health sciences 0302 clinical medicine Ophthalmology Ranibizumab medicine Humans Fluorescein Angiography Aged 80 and over Corneal Dystrophies Hereditary medicine.diagnostic_test business.industry Helicoid peripapillary chorioretinal degeneration Retinal Degeneration General Medicine medicine.disease Fluorescein angiography eye diseases Choroidal Neovascularization medicine.anatomical_structure Choroidal neovascularization Intravitreal Injections 030221 ophthalmology & optometry sense organs medicine.symptom business 030217 neurology & neurosurgery Tomography Optical Coherence Optic disc medicine.drug |
Zdroj: | European journal of ophthalmology. 26(2) |
ISSN: | 1724-6016 |
Popis: | Purpose Helicoid peripapillary chorioretinal degeneration (HPCD) is a hereditary disease of the fundus that is characterized by atrophic chorioretinal areas that appear early in life and expand gradually from the optic disc towards the macula and the periphery. Methods We describe the case of an elderly man with a known diagnosis of HPCD who developed choroidal neovascular membrane (CNV) in both eyes during the course of the disease. Results The patient was treated with intravitreal injection of ranibizumab, to which he had excellent response. The CNV subsided with 2 injections in the right eye and 1 in the left. Two years after the initial diagnosis of CNV in the right eye, visual acuity was 5/10 OD and 9/10 OS. Conclusions Helicoid peripapillary chorioretinal degeneration is rarely complicated by CNV as the fundus lacks the trigger factors that would sustain this process. Although rare, HPCD complicated by CNV can be seen bilaterally, but responds well to few ranibizumab injections. |
Databáze: | OpenAIRE |
Externí odkaz: |